Insights
Search Results
Client Highlights
2.23.26
Firm Advises Arcellx on $7.8 Billion Acquisition by Gilead
On February 23, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire Arcellx, a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, for $115 per share in cash at closing and one contingent value right of $5 per share, which represents an implied equity value of $7.8 billion payable at closing. Wilson Sonsini Goodrich & Rosati advised Arcellx on the transaction.
Client Highlights
7.02.25
Wilson Sonsini Advises Grammarly on Acquisition of Superhuman
On July 1, 2025, Grammarly, the trusted AI assistant for communication and productivity, announced its intent to acquire Superhuman, an AI-native email platform that helps users respond one to two days faster and save four hours per week on email communications. Wilson Sonsini Goodrich & Rosati is advising Grammarly on the transaction.
Client Highlights
6.06.25
Wilson Sonsini Advises Plus on Business Combination with Churchill IX
On June 5, 2025, Plus Automation (Plus), a physical AI company commercializing AI-based virtual driver software for autonomous trucks, and Churchill Capital Corp IX (Churchill IX), a special purpose acquisition company, announced that they have entered into a definitive agreement to effect a business combination. Wilson Sonsini Goodrich & Rosati advised Plus on the transaction.
Client Highlights
4.04.25
Wilson Sonsini Advises Skilljar on Acquisition by Gainsight
On April 2, 2025, Gainsight, a world-leading Customer Success platform that helps business drive growth by unifying the post-sales customer journey, acquired Skilljar, a leading Learning Management Software (LMS) provider for external training. Wilson Sonsini Goodrich & Rosati advised Skilljar on the transaction.
Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.
The Wilson Sonsini team that advised Skilljar on the transaction includes:
Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.
The Wilson Sonsini team that advised Skilljar on the transaction includes:
Client Highlights
7.11.24
Wilson Sonsini Advises Fluent BioSciences on Acquisition by Illumina
On July 9, 2024, Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced that it has acquired Fluent BioSciences (Fluent), developer of an emerging and highly differentiated single-cell technology. Wilson Sonsini Goodrich & Rosati advised Fluent on the transaction.
Client Highlights
6.20.24
Firm Advises Silk Road Medical on $1.26 Billion Acquisition by Boston Scientific
On June 18, 2024, Silk Road Medical announced that it entered into a definitive agreement to be acquired by Boston Scientific Corporation for a purchase price of $27.50 per share, reflecting an aggregate equity value of approximately $1.26 billion. Silk Road Medical is a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR). Wilson Sonsini Goodrich & Rosati advised Silk Road Medical on the transaction.
Client Highlights
2.20.24
Wilson Sonsini Advises VIZIO on $2.3 Billion Acquisition by Walmart
On February 20, 2024, Walmart and VIZIO announced that they have entered into an agreement for Walmart to acquire VIZIO for $11.50 per share in cash, for an equity value of approximately $2.3 billion. Wilson Sonsini Goodrich & Rosati advised VIZIO on the transaction.
Client Highlights
12.19.23
Wilson Sonsini Advises Alteryx in $4.4 Billion Take-Private Deal with Clearlake and Insight Partners
On December 18, 2023, Alteryx (NYSE: AYX), a software company based in Irvine, California, announced that it has entered into a definitive agreement to be acquired by private equity firms Clearlake Capital and Insight Partners for $4.4 billion, including debt. Wilson Sonsini Goodrich & Rosati acted as the legal advisor to Alteryx.
Client Highlights
10.31.23
Wilson Sonsini Advises Lumentum on $750 Million Acquisition of Cloud Light
On October 30, 2023, Lumentum Holdings (Lumentum) and Cloud Light Technology Limited (Cloud Light) announced that they have entered into a definitive agreement under which Lumentum will acquire Cloud Light with a transaction value of approximately $750 million, subject to certain adjustments. At the time of closing, transaction consideration will be paid in cash and the assumption and substitution of outstanding unvested Cloud Light options. The transaction has been unanimously approved by the boards of directors of both companies and by Cloud Light’s shareholders. Lumentum intends to finance the transaction through cash from its balance sheet. The transaction is expected to close by the end of calendar 2023, subject to receipt of regulatory approvals and other customary closing conditions.
Client Highlights
3.15.23
Wilson Sonsini Advises Momentive on $1.5 Billion Acquisition Led by Symphony Technology Group
On March 13, 2023, Momentive, the maker of SurveyMonkey, announced it has entered into a definitive agreement to be acquired by a consortium led by Symphony Technology Group (STG) in an all-cash transaction that values Momentive at approximately $1.5 billion. Wilson Sonsini Goodrich & Rosati is representing Momentive in the transaction.
Client Highlights
9.07.22
Wilson Sonsini Advises Metacrine on Acquisition by Equillium
On September 6, 2022, Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to which Equillium will acquire Metacrine in an all-stock transaction. The transaction is anticipated to add $33 million in cash to Equillium’s balance sheet at closing, which is expected to extend the company’s cash runway into 2024. Wilson Sonsini Goodrich & Rosati is advising Metacrine on the transaction.
Through the acquisition, Equillium adds Metacrine’s farnesoid X receptor (FXR) platform, including lead molecule MET642, an orally delivered FXR agonist that is a potential first-in-class, non-immunosuppressive treatment for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease. The acquisition is anticipated to close late 2022 pending approval from both Equillium and Metacrine shareholders, Metacrine having minimum net cash of $23 million, and other customary closing conditions.
Through the acquisition, Equillium adds Metacrine’s farnesoid X receptor (FXR) platform, including lead molecule MET642, an orally delivered FXR agonist that is a potential first-in-class, non-immunosuppressive treatment for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease. The acquisition is anticipated to close late 2022 pending approval from both Equillium and Metacrine shareholders, Metacrine having minimum net cash of $23 million, and other customary closing conditions.
Client Highlights
4.25.22
Wilson Sonsini Advises Twitter on $44 Billion Acquisition by Elon Musk
On April 25, 2022, Twitter, Inc. announced that it has entered into a definitive agreement to be acquired by an entity wholly owned by Elon Musk in a transaction valued at approximately $44 billion. Upon completion of the transaction, Twitter will become a privately held company. Wilson Sonsini advised Twitter on the transaction.